This research program has focused on characterizing the synapsin family of phosphoproteins and its regulation of neurotransmitter release. By a variety of in vitro and in vivo techniques, we have demonstrated that synapsins are tightly associated with the cytoplasmic face of synaptic vesicles and can bind simultaneously to both synaptic vesicles and actin. Phosphorylation of synapsin I by calcium/calmodulin-dependent protein kinase II (CaMKII) or MAP kinase decreases its affinity for synaptic vesicles and actin, thus allowing vesicles to move within the vesicle cluster from a reserve pool to a readily releasable pool, where they can participate in exocytosis. In addition, we have recently discovered that synapsins directly modulate the dynamics of the readily releasable pool and thus the kinetics of exocytosis. This revised application for renewal proposes to extend our studies on the mechanisms by which synapsins regulate synaptic transmission. To understand the function(s) of synapsins at the molecular level, we propose the following three Specific Aims: I. To determine the impact of synapsin mutations on neurotransmitter release, synaptic vesicle trafficking and the trafficking to and within nerve terminals. We will make use of GFP-labeled synapsins, site-directed mutagenesis, transient cell transfection techniques and live cell imaging combined with physiological approaches for these purposes. II. To study the regulation of Src-family tyrosine kinases by synapsins in nerve terminals. We have previously demonstrated that synapsins are excellent ligands for the Src homology-3 (SH3) domain of c-Src. and that this interaction leads to activation of endogenous vesicle-associated tyrosine kinase, resulting in phosphorylation of endogenous vesicle substrates including synapsins. III. To identify novel binding partners for specific regions of the synapsins and to study their functional significance. Synapsins have been shown to interact with the SH3 domains of c-Src and Grb2. Preliminary results indicate that synapsin-SH3 domain interactions also include many proteins involved in signal transduction and regulation of membrane trafficking at the nerve terminal. We will use in vitro methods to investigate the interactions of synapsins mediated by SH3 domains of proteins relevant to nerve terminal function. We will also investigate those interactions mediated by the highly conserved domains A, C, and E of synapsins. The effects of acute disruption of the identified synapsin interactions on presynaptic morphology and neurotransmitter release will be determined in the in vivo models of the lamprey reticulospinal synapse and the squid giant synapse.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH039327-21
Application #
6723682
Study Section
Special Emphasis Panel (ZRG1-MDCN-1 (01))
Program Officer
Asanuma, Chiiko
Project Start
1983-09-01
Project End
2007-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
21
Fiscal Year
2004
Total Cost
$566,155
Indirect Cost
Name
Rockefeller University
Department
Other Basic Sciences
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Tomiyama, Katsunori; Makihara, Yasuyuki; Yamamoto, Hiroshi et al. (2006) Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'. Eur Neuropsychopharmacol 16:437-45
Venton, B Jill; Seipel, Andrew T; Phillips, Paul E M et al. (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 26:3206-9
Hilfiker, Sabine; Benfenati, Fabio; Doussau, Frederic et al. (2005) Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci 25:2658-69
Nally, Rachel E; Kinsella, Anthony; Tighe, Orna et al. (2004) Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3',5'-monophosphate-regulated phosphoprotein of 32 kDa ""knockout"" mutants congenic on the C57BL/6 genetic back J Pharmacol Exp Ther 310:1281-7
Giovedi, Silvia; Darchen, Francois; Valtorta, Flavia et al. (2004) Synapsin is a novel Rab3 effector protein on small synaptic vesicles. II. Functional effects of the Rab3A-synapsin I interaction. J Biol Chem 279:43769-79
Gitler, Daniel; Xu, Yimei; Kao, Hung-Teh et al. (2004) Molecular determinants of synapsin targeting to presynaptic terminals. J Neurosci 24:3711-20
Giovedi, Silvia; Vaccaro, Paola; Valtorta, Flavia et al. (2004) Synapsin is a novel Rab3 effector protein on small synaptic vesicles. I. Identification and characterization of the synapsin I-Rab3 interactions in vitro and in intact nerve terminals. J Biol Chem 279:43760-8
Gitler, Daniel; Takagishi, Yoshiko; Feng, Jian et al. (2004) Different presynaptic roles of synapsins at excitatory and inhibitory synapses. J Neurosci 24:11368-80
Bloom, Ona; Evergren, Emma; Tomilin, Nikolay et al. (2003) Colocalization of synapsin and actin during synaptic vesicle recycling. J Cell Biol 161:737-47
Nally, Rachel E; McNamara, Fergal N; Clifford, Jeremiah J et al. (2003) Topographical Assessment of Ethological and Dopamine Receptor Agonist-Induced Behavioral Phenotype in Mutants with Congenic DARPP-32 'Knockout'. Neuropsychopharmacology 28:2055-63

Showing the most recent 10 out of 130 publications